Health Economics

(HE-004 (RPT-007)) Early outcomes of implementing a new multilayer foam dressing in an acute setting: assessing clinical and financial impact through value-based procurement

(HE-007 (RPT-008)) Health Economic Assessment of Skin Substitute Graft Use for Diabetic Foot Ulcers in Hospital Outpatient Departments

(HE-001) Purified Native Type I Collagen Matrix Plus Polyhexamethylene Biguanide (PHMB) Antimicrobial Wound Matrix (PCMP) Is Associated With Lower Amputation Rates Among Medicare Beneficiaries With Diabetic Foot Ulcers

(HE-003) Economic Impact of Longitudinal Remote Thermovisual Foot Monitoring in High-Risk Patients With Diabetes: Interim Findings From an Extended Monitoring Cohort

(HE-005) Health resource utilization and cost analysis of Porcine Placental Extracellular Matrix compared to standard of care and other advanced treatments in the treatment of diabetic foot ulcers in the Medicare Fee-For-Service population

(HE-006) Health resource utilization and cost analysis of Porcine Placental Extracellular Matrix compared to standard of care and other advanced treatments in the treatment of venous leg ulcers in the Medicare Fee-For-Service population

(HE-008) Transition of Care - Navigating the Wound Healing Gaps

(HE-009) Cost-Effectiveness of Advanced Wound Modalities in a Mobile Wound Clinic

(HE-010) Clinical and economic impact of a two-layer compression system with zinc, odor, and itch control compared to unna’s boot for the treatment of lower extremity ulcers: a systematic review

(HE-011) Unna problem with the economics: updating lower extremity compression practice from unna boots to a two-layer system with zinc-impregnated foam, odor, and itch control

(HE-012) Rethinking Regulatory Tiers: Medicare Real-World Evidence Shows Cellular, Acellular, and Matrix-Like Product (CAMP) Outcomes Are Independent of FDA Regulatory Classification